Disease-Modifying Treatments for Multiple Sclerosis Affect Measures of Cellular Immune Responses to EBNA-1 Peptides
Authors:
- Lara DunganLDLara Dungan
- Jean DunneJDJean Dunne
- Michael SavioMSMichael Savio
- Marianna KalasziMKMarianna Kalaszi
- Matt McElheronMMMatt McElheron
- Yvonne LynaghYLYvonne Lynagh
- Kate O'DRiscollKOKate O'DRiscoll
- Carmel RocheCRCarmel Roche
- Ammara QureshiAQAmmara Qureshi
- Brendan CrowleyBCBrendan Crowley
- Niall ConlonNCNiall Conlon
- Hugh KearneyHKHugh Kearney
Open Access
- 1 May 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology Neuroimmunology & Neuroinflammation
- Vol. 11 (3) , e200217
Abstract
Background and ObjectivesEpstein-Barr virus (EBV) has been strongly implicated in the pathogenesis of multiple sclerosis (MS). Despite this, there are no routinely used tests to measure cellular response to EBV. In this study, we analyzed the cellular ...Keywords
This publication has 37 references indexed in Scilit:
- Epstein-Barr virus: Biology and clinical diseaseCell, 2022
- Effect of ocrelizumab on leptomeningeal inflammation and humoral response to Epstein-Barr virus in multiple sclerosis. A pilot studyMultiple Sclerosis and Related Disorders, 2022
- The cellular immune response against Epstein-Barr virus decreases during ocrelizumab treatmentMultiple Sclerosis and Related Disorders, 2021
- Massive intracerebral Epstein-Barr virus reactivation in lethal multiple sclerosis relapse after natalizumab withdrawalJournal of Neuroimmunology, 2017
- EBNA1 antigen-specific CD8 + T cells in cerebrospinal fluid of patients with multiple sclerosisJournal of Neuroimmunology, 2016
- High‐throughput sequencing of TCR repertoires in multiple sclerosis reveals intrathecal enrichment of EBV‐reactive CD8+ T cellsEuropean Journal of Immunology, 2014
- Intrathecal immune responses to EBV in early MSEuropean Journal of Immunology, 2010
- Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal studyThe Lancet Neurology, 2010
- Adjusting for multiple testing—when and how?Journal of Clinical Epidemiology, 2001
- Antiviral actions of interferon interferon-regulated cellular proteins and their surprisingly selective antiviral activitiesVirology, 1991